Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The insulin sensitivity pathway refers to the molecular and cellular mechanisms by which cells respond to insulin, a hormone critical for regulating glucose, lipid, and energy homeostasis. This pathway is essential for maintaining normal blood glucose levels and involves a complex network of signaling events initiated when insulin binds to its receptor on target cells such as liver, skeletal muscle, and adipose tissue. Defects at any point in this signaling cascade can lead to reduced cellular responsiveness—termed *insulin resistance*—a hallmark feature of type 2 diabetes mellitus and other cardiometabolic diseases.
Various, depending on the specific target within the pathway. Lifestyle interventions also impact the pathway.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin Sensitivity Pathway.